CJC-1295 No DAC vs Sermorelin: Half-Life, Dosing, and FDA Status

CJC-1295 no DAC and sermorelin are both growth hormone-releasing hormone (GHRH) analogs that signal the pituitary gland to release more growth hormone. The clearest difference is half-life: CJC-1295 no DAC stays active for roughly 30 minutes, while sermorelin clears in about 10 to 20 minutes. That single gap drives nearly every other difference between the two, from injection frequency to blood-level stability and cost per month.

Both are injectable peptides used off-label for body composition, recovery, and sleep quality. Neither is a steroid, and neither contains growth hormone itself.

CJC-1295 No DAC vs Sermorelin at a Glance

The table below summarizes how the two peptides compare on chemistry, dosing, and regulatory status. When people compare cjc-1295 no dac vs sermorelin for the first time, the half-life and FDA rows usually drive the decision.

Feature	CJC-1295 No DAC	Sermorelin
Also known as	Mod GRF (1-29), CJC-1295 without DAC	GRF (1-29), Geref
Structure	Four amino acid substitutions	Native 29-amino-acid sequence
Half-life	About 30 minutes	About 10 to 20 minutes
Typical schedule	1 to 3 injections daily	Once nightly, sometimes twice
DPP-4 resistance	High	Low
FDA status	Never approved for human use	Approved as Geref in 1997, discontinued in 2008; still compounded
Common pairings	Ipamorelin, GHRP-2, GHRP-6	Often used alone

Half-Life and Dosing Frequency

Half-life is the practical dividing line. Sermorelin is broken down quickly by DPP-4 enzymes, so it produces a short, sharp GH pulse that mimics the body's natural nighttime release. CJC-1295 no DAC resists that enzyme, so each injection keeps working longer.

What you find on a cjc-1295 no dac dosage chart typically ranges from 100 mcg to 200 mcg per injection, taken one to three times a day. Sermorelin protocols usually call for 100 mcg to 300 mcg once before bed.

Compound	Typical dose	Frequency	Timing notes
CJC-1295 no DAC	100 to 200 mcg	1 to 3 times daily	Often paired with ipamorelin; last dose before sleep
Sermorelin	100 to 300 mcg	Once nightly	Timed to match the natural GH pulse after sleep onset

These numbers come from clinic protocols and research literature, not from large randomized trials in healthy adults. Individual response varies, and a licensed clinician should set the dose.

What Each Peptide Does in the Body

If you have ever searched what does cjc 1295 no dac do, the answer starts at the pituitary: it binds GHRH receptors and triggers growth hormone release, which in turn raises IGF-1. Sermorelin works through the same receptor.

The end result is similar for both compounds: more endogenous GH, higher IGF-1, and the downstream effects on fat metabolism, muscle repair, and sleep quality that follow. CJC-1295 no DAC is generally considered more potent per microgram because more of the dose survives enzymatic breakdown.

Both peptides depend on a functioning pituitary gland. Neither works well if the gland cannot respond to GHRH signaling.

FDA Status and Availability in the US

CJC-1295 without DAC is not FDA-approved for human use in the United States. It is sold as a research chemical, and vials usually carry a "not for human consumption" label.

Sermorelin has a different history. The FDA approved it in 1997 as Geref for diagnosing and treating growth hormone deficiency, but the brand was discontinued in 2008. Compounding pharmacies still prepare sermorelin with a prescription in many states.

When you see tesamorelin vs sermorelin vs cjc-1295 discussed side by side, remember that tesamorelin (Egrifta) is the only GHRH analog with a current FDA approval, and that approval is limited to HIV-associated lipodystrophy. Sites that let you buy cjc-1295 no dac online are almost always selling unregulated research vials, which means purity, sterility, and actual content are not guaranteed.

Side Effects and Safety Considerations

Because both peptides raise growth hormone, they share a similar side-effect profile. Commonly reported issues include:

• Injection site redness, swelling, or soreness
• Flushing, headache, or lightheadedness soon after dosing
• Water retention and joint aches
• Tingling or numbness in the hands, similar to carpal tunnel symptoms
• Increased hunger, especially when combined with a ghrelin mimetic

More serious concerns come from sustained GH and IGF-1 elevation: insulin resistance, edema, and in rare long-term cases acromegaly-like changes. People with active cancer, uncontrolled diabetes, or who are pregnant should avoid these compounds. Anyone considering them should speak with a licensed healthcare professional first.

Which One Fits Better?

Sermorelin is the conservative option. It follows the body's natural pulse pattern, has a legitimate regulatory history, and can be obtained legally through a compounded prescription.

CJC-1295 no DAC is the more efficient option for people who want fewer injections and stronger receptor activation per dose, but it carries more legal and quality-control risk.

Neither peptide replaces sleep, protein intake, or consistent training. Results attributed to GHRH analogs in online reports tend to be modest and are often confounded by other changes in diet or exercise.

Sermorelin is the only one of these two peptides with any FDA approval history in the United States. CJC-1295 no DAC has roughly double the half-life of sermorelin, which is the main reason it is dosed less frequently and considered more potent per microgram.

COMMON QUESTIONS

Frequently Asked Questions

Is CJC-1295 no DAC stronger than sermorelin?

On a per-microgram basis, CJC-1295 no DAC is generally considered more potent because its four amino acid substitutions make it resistant to DPP-4 breakdown, so more of the dose reaches the pituitary. There are no published head-to-head human trials comparing the two peptides, so the comparison rests on half-life data and clinical reports rather than direct evidence.

Can you get sermorelin legally in the US?

Sermorelin was FDA-approved as Geref until the brand was discontinued in 2008, but licensed clinicians can still prescribe compounded sermorelin from a 503A pharmacy in most states. CJC-1295, with or without DAC, has never been FDA-approved for human use and is sold only as a research chemical.

Can you stack CJC-1295 no DAC and sermorelin together?

Stacking them is generally pointless because both act on the same GHRH receptor, so combining them does not add a new signaling pathway. Most protocols pair a GHRH analog with a ghrelin mimetic such as ipamorelin instead, which binds a different receptor and can amplify the growth hormone pulse.